The U.S. drug regulator has flagged three quality and procedural lapses at Ipca Laboratories Ltd.’s formulations manufacturing unit located at Piparia in Silvassa.”The U.S. FDA conducted the inspection of the company’s formulations manufacturing unit situated at Piparia (Silvassa) from April 18 to April 26,” the company had said in an…Read More
Ipca Laboratories Faces US FDA Scrutiny Over Three Lapses At Silvassa Facility BQ Exclusive
